26 affective-computing-"https:"-"https:"-"https:" PhD positions at The University of Manchester
Sort by
Refine Your Search
-
-wzn23), this project will combine advanced synthetic strategies with reactivity studies, detailed physical characterization and computational studies to elucidate electronic structures. Together
-
before the deadline. Computational haemodynamic modelling provides a powerful framework for linking blood flow dynamics with cardiovascular disease, using in silico approaches to systematically study flow
-
theoretical and practical skills training provided by a mixture of industry and academic project partners covering structural biology; biophysical and analytical methods; computational modelling; directed
-
computational protein design to develop new biocatalytic methods for asymmetric synthesis. This collaborative project will leverage the pyridoxal phosphate (PLP)-dependent enzyme UstD, previously developed
-
molecules, such as preservatives and fragrance ingredients play key roles within personal and home care products. When they are included in surfactant-based formulations, their impact can be greatly enhanced
-
to structural design models to quantify the potential impact on key drivers of offshore wind farm economics. Specifically the impact of advanced wake models on wind farm energy yield forecasts, hence revenue, and
-
aluminium alloys processed via advanced thermomechanical process. Key questions include: i) how does quenching affect precipitate formation, PFZs, and thus the thermomechanical ageing process response; ii
-
., blockchains), AI safety, and privacy, with potential impact across domains such as finance and healthcare. Applicants are expected to have an MSc degree in computer science or other majors related
-
in the groups of Dr Florence Hardy and Prof Anthony Green, University of Manchester, as part of the cross-institutional BioAID Doctoral Training Programme, including world-leading experts from Queen's
-
compounds often has a profound impact on their physicochemical properties and biological activity. In collaboration with colleagues at AstraZeneca, we will design novel homologation strategies for use in drug